chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Mobility decreased, Musculoskeletal disorder, Pain in extremity
Clinical narrative: This health authority case was initially received on 22-Jan-2016. The case report was received from a Health Professional and concerns a 48 years old female patient. Weight: not provided, Height: not provided. The patient had no medical history or current illness. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/ event (s): The patient received AFLURIA for indication not reported on 11-Nov-2015- unknown stop date, Batch no: U50509 (reported as '450509' not valid CSL batch), Route of administration: SYR, Dose: 0.5 ml, Site: arm. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/ event (s) and outcome: On 12-Nov-2015, 2 days after starting/treatment with AFLURIA the patient experienced Pain in the hand (non serious, outcome: Unknown), Could not lift or use the arm (non serious, outcome: Unknown), Pain at injection site (non serious, outcome: Unknown).
Age: 59.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Movement disorder, Musculoskeletal pain, Pain
Clinical narrative: This health authority case was initially received on 22-Jan-2016. This case report was received from a Health Professional and concerns a 59 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Latex allergy, Crushed leg many years ago and Limited mobility. The patient had no medical history or current illness. It was unknown if she had medications at time of vaccination. The patient received AFLURIA on 10-Dec-2015 - unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml, Site: left arm. On the same day, the patient received PNEUMOVAX (batch no: K00840) via intramuscular route in the left arm about 2 inches apart from the AFLURIA injection, Indication: not provided. On 10-Dec-2015, after starting/treatment with AFLURIA the patient experienced Received PNEUMOVAX 23 and AFLURIA left arm IM about 2 inches apart. On 11-Dec-2015, morning after starting/treatment with AFLURIA, upon waking, the patient experienced Difficulty lifting all limbs, Shooting pain down legs, Aching buttocks, Pain. Reporter's assessment: Non serious. The health authority reported additional term pain. VAERS ID: 614618.
Age: 30.0
Sex: M
Vaccine: FLU3
Symptoms: Abdominal distension, Back pain, Erythema
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 30 years old male patient. Weight: not provided, Height: not provided. The patient has a medical history of Adverse reaction to food and Urticaria. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 07-Dec-2015 - unknown stop date, Batch no: U50309, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 08-Dec-2015, 2 days after starting/treatment with AFLUIRIA the patient experienced Tightness abdomen, Redness chest and back, Pinch in back feeling. The patient was treated with increased dose of cetirizine to one tablet oral (bid) and started on topical fluocinonide. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS: 615015.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Nausea
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a(n) Health Professional and concerns a(n) 55 years old female patient. Linked to case: US-BEH-2016060275 (same patient). Weight: not provided, Height: not provided. The patient has a medical history of allergy to "dust mites, nuts, fish, penicillin, cephalosporin and macrolides. The patient received AFLURIA on 12-Dec-2015, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 12-Dec-2015, in four hours, the patient experienced fever and aching. 12 hours later, the patient had fever, her arm was swollen, upper joints ached and developed chills. Three days later, she had fever, chills, fatigue, nauseous, both arms and elbow ache and dizzy. She was starting to improve. Outcome was reported as recovered. Reporter's assessment: non-serious.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Peripheral swelling, Pyrexia
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a(n) Health Professional and concerns a(n) 55 years old female patient. Linked to case: US-BEH-2016060275 (same patient). Weight: not provided, Height: not provided. The patient has a medical history of allergy to "dust mites, nuts, fish, penicillin, cephalosporin and macrolides. The patient received AFLURIA on 12-Dec-2015, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 12-Dec-2015, in four hours, the patient experienced fever and aching. 12 hours later, the patient had fever, her arm was swollen, upper joints ached and developed chills. Three days later, she had fever, chills, fatigue, nauseous, both arms and elbow ache and dizzy. She was starting to improve. Outcome was reported as recovered. Reporter's assessment: non-serious.
Age: 73.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Chills, Fatigue, Feeling abnormal, Injection site erythema, Injection site pain
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 73 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Allergies: sulfa drugs, antihyperlipidemics, ZOLOFT, Allergies: Ivory soap, Hyperlipidemia, DM type II, Insulin resistance with hirsutism, Hypothyroidism and HTN. The patient's current illness was reported as "wellness exam". For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 14-Dec-2015 - unknown stop date, Batch no: 11749221A, Route of administration: Intramuscular, site: left arm. On the same day the patient received PNEUMOVAX, batch no. L022262, site: right arm, Indication: not provided. On 14-Dec-2015, 1 day after starting treatment with AFLURIA the patient experienced Extreme fatigue, Feeling very bad, Fever, Chills, Injection site redness, Injection site hot to touch, Injection site soreness/tenderness. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 615094.
Age: 73.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site warmth, Pyrexia
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 73 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Allergies: sulfa drugs, antihyperlipidemics, ZOLOFT, Allergies: Ivory soap, Hyperlipidemia, DM type II, Insulin resistance with hirsutism, Hypothyroidism and HTN. The patient's current illness was reported as "wellness exam". For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 14-Dec-2015 - unknown stop date, Batch no: 11749221A, Route of administration: Intramuscular, site: left arm. On the same day the patient received PNEUMOVAX, batch no. L022262, site: right arm, Indication: not provided. On 14-Dec-2015, 1 day after starting treatment with AFLURIA the patient experienced Extreme fatigue, Feeling very bad, Fever, Chills, Injection site redness, Injection site hot to touch, Injection site soreness/tenderness. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 615094.
Age: 33.0
Sex: M
Vaccine: FLU3
Symptoms: Dry eye, Eye pruritus, Pruritus generalised
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 33 years old male patient. Weight: not provided, Height: not provided. The patient has a medical history of Asthma. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 14-Dec-2015 - unknown stop date, Batch no: U50909, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 14-Dec-2015, the patient's eyes began itching and a few hours later his body was itching. The patient did not notice any rash or hives. The patient was treated with loratadine at 6 pm and then received diphenhydramine at 10 pm. On 15-Dec-2015 morning, the patient took 50 mg diphenhydramine at 11 am, 2 pm and 6 pm and took a loratadine sometime in the morning. The patient felt that he was getting better. On 16-Dec-2015, the patient did not take any medication. The patient stated that his eyes were dry and he had to throw a contact away. The outcome was recovered. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 615307. Case correction (29-Mar-2016): AE 2 recoded to 'generalized itching'.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 46 year old female patient. Concurrent medical conditions (s), medical and drug history: The patient has a medical history of Type II diabetes mellitus, Increased blood pressure, Anxiety, Gastroesophageal reflux syndrome, Diabetic neuropathy, Knee pain, Hypertriglyceridemia, Female stress incontinence, Chest pain, Abdominal pain, Vomiting, Neuroma of foot and Allergic reaction (due to correct medicinal product properly administered). The following drug history information was reported. TDAP (Indication: -, Reaction: Local site edema), TDAP (Indication: -, Reaction: Local site erythema) and VICODIN, PERCOCET, Betadine, Sulfa (Indication: -, Reaction: Allergy). Suspect drug (s) timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 29-Sep-2015- unknown stop date: Batch no: 11849211A, Route of administration: Unknown, Site: Left arm (LA). Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 29-Sep-2015, 1 day after starting/ treatment with AFLURIA the patient experienced Swollen at local site (non serious, outcome: Recovered/ Resolved), Red at local site (non serious, outcome: Recovered/ Resolved), Itching at local site (non serious, outcome: Recovered/ Resolved).
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pyrexia, Skin warm
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 51 years old male patient. Weight: not provided, Height: not provided. Concurrent medical condition (s), medical and drug history: The patient has a medical history of Allergic to aspirin and Type 2 diabetes. The following drug history inflammation was reported: Aspirin (Indication-, Reaction: Allergy). For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 12-Dec-2015- unknown stop date, Batch no: U57907, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. Additional suspect drug (s): PNEUMOVAX, batch number: L024132, site: left arm, Indication: not provided. Both the vaccines were given in the same arm (medication error not explicitly reported). Reaction (s)/ event (s) and outcome: On 12-Dec-2015, 1 day after starting/ treatment with AFLURIA the patient experienced arm extremely sore (non serious, outcome: Recovered/ Resolved), Fever (non serious, outcome: Recovered/ Resolved), Arm red (non serious, outcome: Recovered/ Resolved), Arm swollen (half dollar coin size) (non serious, outcome: Recovered/ Resolved), Arm very warm to the touch (non serious, outcome: Recovered/ Resolved). For relevant test results see appropriate report section.
Age: 90.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Pain, Peripheral coldness
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 90 years old female patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 10-Dec-2015 - unknown stop date, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 10-Dec-2015, 1 day after starting/ treatment with AFLURIA the patient experienced Numbness (non serious, outcome: Not Recovered/ Not Resolved), Pain (non serious, outcome: Not Recovered/Not Resolved), Cold fingers (non serious, outcome: Not Recovered/ Not Resolved). Event treatment: Ibuprofen (800 mg) and pregabalin (75 mg). For relevant test results see appropriate report section.
Age: 54.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Fatigue, Malaise, Pain, Rash, Skin exfoliation
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 54 years old male patient. Weight: not provided, Height: not provided. Concurrent medical condition (s), medical and drug history: The patient has a medical history of Rheumatoid arthritis, Anxiety and Lack functional spleen. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 04-Dec-2015- unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml. Additional suspect drug (s): PREVNAR 13 batch number; M03211, Indication: not provided. Reaction (s)/event (s) and outcome: On 07-Dec-2015, 4 days after starting/ treatment with AFLURIA the patient experienced Tender face (non serious, outcome: Recovered/ Resolved), Tender scalp (non serious, outcome: Recovered/ Resolved), Malaise (non serious, outcome: Recovered/ Resolved), Aching (non serious, outcome: Recovered/ Resolved), Fatigue (non serious, outcome: Recovered/ Resolved), Rash (non serious, outcome: Recovered/ Resolved), Skin peeling on forehead (non serious, outcome: Recovered/ Resolved), starting three days after vaccine which lasted for about 7 days. For relevant test results see appropriate report section.
Age: 54.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Tenderness
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 54 years old male patient. Weight: not provided, Height: not provided. Concurrent medical condition (s), medical and drug history: The patient has a medical history of Rheumatoid arthritis, Anxiety and Lack functional spleen. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 04-Dec-2015- unknown stop date, Batch no: U59208, Route of administration: Intramuscular, Dose: 0.5 ml. Additional suspect drug (s): PREVNAR 13 batch number; M03211, Indication: not provided. Reaction (s)/event (s) and outcome: On 07-Dec-2015, 4 days after starting/ treatment with AFLURIA the patient experienced Tender face (non serious, outcome: Recovered/ Resolved), Tender scalp (non serious, outcome: Recovered/ Resolved), Malaise (non serious, outcome: Recovered/ Resolved), Aching (non serious, outcome: Recovered/ Resolved), Fatigue (non serious, outcome: Recovered/ Resolved), Rash (non serious, outcome: Recovered/ Resolved), Skin peeling on forehead (non serious, outcome: Recovered/ Resolved), starting three days after vaccine which lasted for about 7 days. For relevant test results see appropriate report section.
Age: 35.0
Sex: M
Vaccine: FLU3
Symptoms: Pain
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 35 years old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 24-Nov-2015 - unknown stop date, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 24-Nov-2015, after starting/treatment with AFLURIA the patient experienced Pain ever since he received vaccination (vaccination site). The patient denied constant aching at the vaccination site, swelling or bruising. The patient had tried to massage it but the pain had not improved. The patient called into the pharmacy on 19-Dec-2015 at 05:30 pm, to report that he had experienced pain ever since he received the vaccination. The patient was advised to take ibuprofen/acetaminophen to help with the pain. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS: 615664.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 64 years old female patient. Weight: not provided, Height: not provided. Concurrent medical condition (s), medical and drug history: The patient has a medical history of COPD. For concomitant medication and therapy dates refer to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/ event (s): The patient received AFLURIA for indication not reported on 15-Dec-2015- unknown stop date, Batch no: U51009, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/ event (s) and outcome: On 16-Dec-2015, 2 days after starting/ treatment with AFLURIA the patient experienced swelling at injection site (non serious, outcome: Recovered/ Resolved), Redness at the injection site (non serious, outcome: Recovered/ Resolved). For relevant test results see appropriate report section.
Age: 19.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 19 year old female patient. The patient had no illness at the time of vaccination. Suspect drug (s), timing and conditions surround the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 21-Dec-2015- unknown stop date, Batch no: U56006, Route of administration: Intramuscular, Dose: 0.5 ml, Site: Right deltoid. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 21-Dec-2015 14:00, 30 mins after starting/ treatment with AFLURIA the patient experienced itching under right arm (non serious, outcome: Unknown), Hives under right arm (non serious, outcome: Unknown).
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 37 years old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA for on 07-Dec-2015 - unknown stop date, Batch no: U58608, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 22-Dec-2015, 2 weeks 2 days after starting / treatment with AFLURIA the patient experienced Soreness in the arm of Injection. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 616021.
Age: 37.0
Sex: M
Vaccine: FLU3
Symptoms: Blister, Pain
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 37 years old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refers to the appropriate report sections. Suspect drug (s), timing and conditions surrounding the onset of reaction (s)/event (s): The patient received AFLURIA for indication not reported on 16-Dec-2015 - unknown stop date, Batch no: U57207, Route of administration: Intramuscular, Dose: 0.5 ml, site: unknown. Additional suspect drug (s): No additional drugs suspected. Reaction (s)/event (s) and outcome: On 16-Dec-2015, 2 days after vaccination the patient experienced sore (non serious, outcome: Recovered/ Resolved) for 3-4 days. He took the band aid off and saw a blister (non serious, outcome: Recovered/ Resolved). The blister was filled with red liquid. For relevant test results see appropriate report section.
Age: 29.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Skin discolouration, Skin mass
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a(n) Health Professional and concerns a(n) 29 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Allergic to penicillin. The patient received AFLURIA on 07-Oct-2015, Batch no: not provided, Route of administration: not provided, Dose: 0.5 ml, Site: Right arm. No additional drugs suspected. On 07-Oct-2015, the AFLURIA shot produced a large painful lump under the skin. The lump was smaller but the skin was discolored. Three months later, it looks/feels like a scar or bruise. The outcome was reported as missing. Reporter's assessment: non-serious.
Age: 82.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Erythema, Injection site warmth, Pyrexia
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns an 82 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Morphine, codeine, Norco, PCN, losartan (allergy). The following drug history information was reported: Morphine (Indication: -, Reaction: Allergy), Codeine (Indication: -, Reaction: Allergy), Norco (Indication: -, Reaction: Allergy), PCN (Indication: -, Reaction: Allergy), and Losartan (Indication: -, Reaction: Allergy). For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 17-Dec-2015 - unknown stop date, Batch no: 12349211A, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. Additional suspect drug: PREVNAR 13, batch number: M20640, Indication: not provided, site: right arm. On 07-Dec-2015, 1 day after receiving AFLURIA, the patient had fever, redness and the site was warm to touch. Her current illness included fever, redness and warm to touch on the right deltoid. Event treatment: Sulfamethoxazole and trimethoprim at 800 mg-160 mg 1 tablet BID. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 616083.
Age: 49.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Erythema, Inflammation, Pain in extremity, Pyrexia
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a(n) Health Professional and concerns a(n) 49 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Diabetes. She had no allergies or defects from medications for blood pressure, diabetes and cholesterol. The patient received AFLURIA on 09-Dec-2015, Batch no: U50509, Route of administration: Unknown, Dose: 0.5 ml, site: left arm. Additional suspect drug(s): PNEUMOVAX, batch number: L003186, site: left arm and ADACEL, batch number: U5292AA, site: right arm. AFLURIA and PNEUMOVAX given in same arm. On 09-Dec-2015, 2 days after later the patient red, inflammation and pain on left arm. The patient was sure that it was radiating from the Pneumonia shot. It lasted 2 weeks. She had fever of around 101 degree F for four days. The outcome was reported as recovered. Reporter's assessment: non-serious.
Age: 37.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a(n) Health Professional and concerns a(n) 37 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 30-Nov-2015, Batch no: U58808, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. Additional suspect drug(s): ADACEL, batch #: U52354, site: left arm. Both the vaccines were given in the same arm. On 24-Dec-2015, 3 weeks 4 days after starting treatment with AFLURIA the patient experienced Sore arm, Tingling arm. Event treatment: acetaminophen relieved the pain. Reporter's assessment: non-serious.
Age: 48.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Drug administered at inappropriate site, Injection site pain
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a(n) Health Professional and concerns a(n) 48 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 12-Oct-2015, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 12-Oct-2015, the patient received the shot too close to the shoulder. On an unknown date, after receiving AFLURIA the patient's shoulder still hurts. Reporter's assessment: non-serious. The health authority reported symptom included 'injection site pain'.
Age: 48.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Drug administered at inappropriate site, Injection site pain, Musculoskeletal pain
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a(n) Health Professional and concerns a(n) 48 years old female patient. Weight: not provided, Height: not provided. The patient received AFLURIA on 12-Oct-2015, Batch no: U58407, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 12-Oct-2015, the patient received the shot too close to the shoulder. On an unknown date, after receiving AFLURIA the patient's shoulder still hurts. Reporter's assessment: non-serious. The health authority reported symptom included 'injection site pain'.
Age: 34.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Blood test normal, Computerised tomogram normal, Headache, Lumbar puncture normal, Muscular weakness
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 34 years old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 19-Nov-2015 - unknown stop date, Batch no: U56206, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 21-Nov-2015, 3 days after starting treatment with AFLURIA the patient experienced Bilat LE (lower extremity) weakness/Progressed into bilat UE (upper extremity). These symptoms started axially and progressed into the feet and hands. He also developed "sore muscle pain" and pain in extremity. He denied any difficulty with breathing or swallowing. There was no proceeding symptom of viral or bacterial infection. The patient went to ER (emergency room) for care and had a full w/u (workup) to include multiple spinal taps, blood work and CT (computer tomography) scan, all of which were non-diagnostic. The patient was sent home with medication for symptomatic relief. The symptoms slowly resolved over the course of two weeks. The patient denied any residual symptoms and had a normal physical examination. For relevant test results see appropriate report section. Reporter's assessment: non-serious. The health authority added additional term pain in extremity. VAERS ID: 617555. Case corrections (22-Mar-2016): AE 1 upgraded to a serious AE. Case correction 12-Apr-2016: Verbatim for AE 1 changed from 'Bilat LE weakness/Progressed into bilat UE' to 'Bilat LE (lower extremity) weakness/Progressed into bilat UE (upper extremity)'.
Age: 34.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Myalgia, Pain in extremity
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 34 years old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 19-Nov-2015 - unknown stop date, Batch no: U56206, Route of administration: Intramuscular, Dose: 0.5 ml, site: left arm. No additional drugs suspected. On 21-Nov-2015, 3 days after starting treatment with AFLURIA the patient experienced Bilat LE (lower extremity) weakness/Progressed into bilat UE (upper extremity). These symptoms started axially and progressed into the feet and hands. He also developed "sore muscle pain" and pain in extremity. He denied any difficulty with breathing or swallowing. There was no proceeding symptom of viral or bacterial infection. The patient went to ER (emergency room) for care and had a full w/u (workup) to include multiple spinal taps, blood work and CT (computer tomography) scan, all of which were non-diagnostic. The patient was sent home with medication for symptomatic relief. The symptoms slowly resolved over the course of two weeks. The patient denied any residual symptoms and had a normal physical examination. For relevant test results see appropriate report section. Reporter's assessment: non-serious. The health authority added additional term pain in extremity. VAERS ID: 617555. Case corrections (22-Mar-2016): AE 1 upgraded to a serious AE. Case correction 12-Apr-2016: Verbatim for AE 1 changed from 'Bilat LE weakness/Progressed into bilat UE' to 'Bilat LE (lower extremity) weakness/Progressed into bilat UE (upper extremity)'.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Laboratory test, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA, batch number: 11049221A in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received. The outcome was unknown. The health authority assessed the events as non-serious.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA, batch number: 11049221A in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received. The outcome was unknown. The health authority assessed the events as non-serious.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA injection (batch number: 11049221A) in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received. The outcome was unknown.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA injection (batch number: 11049221A) in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received as the patient was not seen at the sponsored clinic. The outcome was unknown. Reporter's comments: The health authority assessed the events as non-serious. VAERS ID: 617668.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Laboratory test, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA, batch number: 11049221A in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received as the patient was not seen at the sponsored clinic and was tested through private physician. The outcome was unknown. The health authority assessed the events as non-serious.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA, batch number: 11049221A in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received as the patient was not seen at the sponsored clinic and was tested through private physician. The outcome was unknown. The health authority assessed the events as non-serious.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA injection (batch number: 11049221A) in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received as the patient was not seen at the sponsored clinic. The outcome was unknown. Reporter's comments: The health authority assessed the events as non-serious. VAERS ID: 617674.
Sex: U
Vaccine: FLU3, FLU3
Symptoms: Incorrect product storage, Multiple use of single-use product, Underdose, Wrong technique in product usage process
Clinical narrative: This medically confirmed health authority report (initial receipt 22-Feb-2016) concerns a patient (gender: unknown). On 30-Sep-2015, the nurse had re-used the syringe for multiple patients at an employee influenza vaccination clinic. The nurse brought three multiple dose vials of the vaccine that were intended for another event and were stored in her personal fridge without temperature monitoring. The nurse reported using two syringes she found in her supplies to administer vaccine to 67 patients. She reported wiping the syringes with alcohol and using a new needle for each patient. Only 2 multiple dose vials of vaccines (10 doses/vial) were used for 67 adult patients. This patient (one of the 67 patients) was administered intramuscular AFLURIA, batch number: 11049221A in the arm. The patient was offered blood pathogen testing (hep B, hep C, HIV), hepatitis B vaccine and flu vaccine. However, the test results were not received as the patient was not seen at the sponsored clinic. The outcome was unknown. Reporter's comments: The health authority assessed the events as non-serious.
Age: 81.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Chills, Night sweats, Pyrexia
Clinical narrative: This health authority case was initially received on  22-Feb-2016. The case report was received from a Health Professional and concerns an 81 year old male patient. Weight: not provided, Height: not provided. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 23-Oct-2015 - unknown stop date, Batch no: 11849221A, Route of administration: Unknown, Dose: 0.5 ml, site; Left arm. No additional drugs suspected. On 17-Dec-2015, 8 weeks 0 days after starting / treatment with AFLURIA the patient experienced Night sweats, Fever, Rigors. For relevant test results see appropriate report section. Reporter's Assessment: non-serious. VAERS ID: 617957.
Age: 43.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Headache, Lymphadenitis
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 43 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Seizure disorder due to car accident. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 06-Jan-2016 - unknown stop date, Batch no: U56807, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. PNEUMOVAX, batch no. L035687, Site: left arm. On 07-Jan-2016, 2 days after AFLURIA the patient experienced Lymphadenitis on axillae and neck (left side only) and a headache. There was no injection site reaction. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 617969.
Age: 11.0
Sex: F
Vaccine: FLU3, HPV9, FLU3, HPV9
Symptoms: Blood pressure increased, Body temperature increased, Chills, Feeling cold, Feeling hot
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 11 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Acne. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 10-Jan-2016 - unknown stop date, Batch no: 11849211A, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. GARDASIL 9, batch no. L019286, site: left arm. On 10-Jan-2016, approximately 1-2 minutes after receiving vaccinations the patient experienced Slight puffiness in cheeks, Felt hot, Felt cold, Shivering, Elevated heart rate, Temperature 100.2 Fahrenheit, Elevated blood pressure, Flushed face. The events lasted approximately 2 hours. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 618393.
Age: 11.0
Sex: F
Vaccine: FLU3, HPV9, FLU3, HPV9
Symptoms: Flushing, Heart rate increased, Swelling face
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 11 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Acne. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 10-Jan-2016 - unknown stop date, Batch no: 11849211A, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. GARDASIL 9, batch no. L019286, site: left arm. On 10-Jan-2016, approximately 1-2 minutes after receiving vaccinations the patient experienced Slight puffiness in cheeks, Felt hot, Felt cold, Shivering, Elevated heart rate, Temperature 100.2 Fahrenheit, Elevated blood pressure, Flushed face. The events lasted approximately 2 hours. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 618393.
Age: 11.0
Sex: F
Vaccine: FLU3, HPV9, FLU3, HPV9
Symptoms: Flushing, Heart rate increased, Swelling
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 11 years old female patient. Weight: not provided, Height: not provided. The patient has a medical history of Acne. For concomitant medication and therapy dates refer to the appropriate report sections. The patient received AFLURIA on 10-Jan-2016 - unknown stop date, Batch no: 11849211A, Route of administration: Intramuscular, Dose: 0.5 ml, site: right arm. GARDASIL 9, batch no. L019286, site: left arm. On 10-Jan-2016, approximately 1-2 minutes after receiving vaccinations the patient experienced Slight puffiness in cheeks, Felt hot, Felt cold, Shivering, Elevated heart rate, Temperature 100.2 Fahrenheit, Elevated blood pressure, Flushed face. The events lasted approximately 2 hours. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 618393.
Age: 48.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site pruritus, Pruritus
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 48 years old female patient. The patient had severe allergy to latex and was given the latex free shot. Weight: not provided, Height: not provided. The patient has a medical history of Anaphylaxis shock. For concomitant medication and therapy dates refers to the appropriate report sections. The patient received AFLURIA on 12-Nov-2015 - unknown stop date, Batch no: not provided, Route of administration, not provided, Dose: 0.5 ml, site: right arm. No additional drugs suspected. On 12-Nov-2015, within minutes after receiving AFLURIA the patient experienced Hands and neck became very red, Itchiness at the site, Itchiness [at site] then from waist up. The events lasted 2 days. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 618430.
Age: 48.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Erythema, Injection site pruritus, Pruritus
Clinical narrative: This health authority case was initially received on 22-Feb-2016. The case report was received from a Health Professional and concerns a 48 years old female patient. The patient had severe allergy to latex and was given the latex free shot. Weight: not provided, Height: not provided. The patient has a medical history of Anaphylaxis shock. For concomitant medication and therapy dates refers to the appropriate report sections. The patient received AFLURIA on 12-Nov-2015 - unknown stop date, Batch no: not provided, Route of administration, not provided, Dose: 0.5 ml, site: right arm. No additional drugs suspected. On 12-Nov-2015, within minutes after receiving AFLURIA the patient experienced Hands and neck became very red, Itchiness at the site, Itchiness [at site] then from waist up. The events lasted 2 days. For relevant test results see appropriate report section. Reporter's assessment: non-serious. VAERS ID: 618430.